SCHEMBL6537656

SCHEMBL6537656

CN1CCN(c2c(CO[Si](C)(C)C(C)(C)C)cnc3c(NC(=O)c4c(Cl)cccc4Cl)cccc23)C1=S

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
NPC1 O15118 2/20 0.32
LCK P06239 1/20 0.32
MAPK14 Q16539 1/20 0.32
P2RX7 Q99572 2/20 0.32
KDM4E B2RXH2 2/20 0.31
TSHR P16473 2/20 0.31
HSD17B10 Q99714 1/20 0.31
MAPK8 P45983 2/20 0.31
HDAC3 O15379 1/20 0.31
NCOR1 O75376 1/20 0.31
CDK1 P06493 1/20 0.31
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
LMNA P02545 2/20 0.31
HTT P42858 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538181 0.92 MEN1 (0.34) MEN1KMT2ANPC1LCKMAPK14
SCHEMBL6537953 0.89 PTGES (0.37) MEN1KMT2ANPC1LCKMAPK14
SCHEMBL6537474 0.87 LCK (0.36) MEN1KMT2ANPC1LCKMAPK14
SCHEMBL6538154 0.82 MAPT (0.38) NPC1LCKMAPK14KDM4ETSHR
SCHEMBL8477159 0.82 TYK2 (0.38) MEN1KMT2ATSHRHDAC3NCOR1
SCHEMBL6537657 0.80 PTGES (0.37) MEN1KMT2ANPC1LCKMAPK14
SCHEMBL6537963 0.80 PTGES (0.37) MEN1KMT2ALCKMAPK14JAK2
SCHEMBL6537499 0.79 KMT2A (0.35) MEN1KMT2ANPC1LCKMAPK14
SCHEMBL6537705 0.78 MEN1 (0.37) MEN1KMT2ANPC1LCKMAPK14
SCHEMBL6537516 0.76 SMN1; SMN2 (0.34) MEN1KMT2ATSHRHDAC3NCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed